Effects of host factors, virulent starins, and bacteriophage on therapies of Clostridium difficile infection including fecal microbiota transplantatio
Phase 1
Recruiting
- Conditions
- Clostridium difficile infection
- Registration Number
- JPRN-UMIN000021126
- Lead Sponsor
- Fujita Health University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1)Allergy to drugs used 2)Pregnant or probably pregnant women 3)Patients who are considered unsuitable by doctors
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pre-treatment differences of Clostridium difficile strains(toxinA/B, binary toxin, PCR-ribotype) among vancomycin-sensitive, FMT-sensitive, and FMT-resistant groups
- Secondary Outcome Measures
Name Time Method 1. Pre-treatment differences of host factors and phages among vancomycin-sensitive, FMT-sensitive, and FMT-resistant groups 2. Changes of Clostridium difficile strains(toxinA/B, binary toxin, PCR-ribotype) and phages 8 and 24 weeks after FMT